Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNVNR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,047
Award facts
- Contract value 100% obligated
- $44,046.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,046.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The contract, which is expected to be completed by August 12, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same municipality. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which establishes a comprehensive pharmaceutical prime vendor vehicle for global military healthcare support.
Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma. This delivery order supports the Defense Health Agency's pharmaceutical supply requirements for military beneficiaries and service members. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates significant experience in distributing specialty pharmaceuticals, brand-name medications, and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. The company's capacity to fulfill this order reflects its established capabilities as a critical vendor within the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DB25FNVNR?
SPE2DB25FNVNR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FNVNR worth?
The government has obligated $44,047 on SPE2DB25FNVNR.
Is contract SPE2DB25FNVNR an order under another contract?
Yes. SPE2DB25FNVNR is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVNR competed?
The extent of competition for SPE2DB25FNVNR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award